<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37845463</PMID><DateCompleted><Year>2023</Year><Month>11</Month><Day>02</Day></DateCompleted><DateRevised><Year>2023</Year><Month>11</Month><Day>02</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0065-2598</ISSN><JournalIssue CitedMedium="Print"><Volume>1438</Volume><PubDate><Year>2023</Year></PubDate></JournalIssue><Title>Advances in experimental medicine and biology</Title><ISOAbbreviation>Adv Exp Med Biol</ISOAbbreviation></Journal><ArticleTitle>Reduced Cerebrovascular Oxygenation in Individuals with Post-Acute COVID-19 Syndrome (PACS) ("long COVID").</ArticleTitle><Pagination><StartPage>211</StartPage><EndPage>216</EndPage><MedlinePgn>211-216</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/978-3-031-42003-0_33</ELocationID><Abstract><AbstractText>There is evidence that hypoxia occurs in the brain of some individuals who contracted the COVID-19 disease. Furthermore, it has been widely reported that about 13% of individuals who contracted the COVID-19 disease report persistent symptoms after the acute infection stage (&gt;2&#xa0;months post-acute infection). This is termed post-acute COVID-19 syndrome (PACS) or ("long COVID"). In this study, we aimed to determine if hypoxia measured non-invasively with frequency domain near-infrared spectroscopy (fdNIRS) occurs in asymptomatic and symptomatic individuals with post-acute COVID-19 disease. We show that 26% of our symptomatic group, measured on average 9.6&#xa0;months post-acute COVID-19 disease, were hypoxic and 12% of the asymptomatic group, measured on average 2.5&#xa0;months post-acute infection, were hypoxic. Our study indicates that fdNIRS measure of hypoxia in the brain may be a useful tool to identify individuals that are likely to respond to treatments targeted at reducing inflammation and improving oxygenation.</AbstractText><CopyrightInformation>&#xa9; 2023. The Author(s), under exclusive license to Springer Nature Switzerland AG.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Adingupu</LastName><ForeName>Damilola D</ForeName><Initials>DD</Initials><AffiliationInfo><Affiliation>Department of Radiology, University of Calgary, Calgary, AB, Canada. Deborah.adingupu@ucalgary.ca.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Soroush</LastName><ForeName>A</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Radiology, University of Calgary, Calgary, AB, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Hotchkiss Brain Institute, University of Calgary, Calgary, AB, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Clinical Neurosciences, University of Calgary, Calgary, AB, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hansen</LastName><ForeName>A</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Radiology, University of Calgary, Calgary, AB, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Clinical Neurosciences, University of Calgary, Calgary, AB, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Twomey</LastName><ForeName>R</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Faculty of Kinesiology, University of Calgary, Calgary, AB, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dunn</LastName><ForeName>J F</ForeName><Initials>JF</Initials><AffiliationInfo><Affiliation>Department of Radiology, University of Calgary, Calgary, AB, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Hotchkiss Brain Institute, University of Calgary, Calgary, AB, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Clinical Neurosciences, University of Calgary, Calgary, AB, Canada.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Adv Exp Med Biol</MedlineTA><NlmUniqueID>0121103</NlmUniqueID><ISSNLinking>0065-2598</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>S88TT14065</RegistryNumber><NameOfSubstance UI="D010100">Oxygen</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010100" MajorTopicYN="Y">Oxygen</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000860" MajorTopicYN="N">Hypoxia</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001921" MajorTopicYN="N">Brain</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Cerebrovascular oxygenation</Keyword><Keyword MajorTopicYN="N">Hypoxia</Keyword><Keyword MajorTopicYN="N">Long COVID</Keyword><Keyword MajorTopicYN="N">Post-acute COVID-19 syndrome</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>11</Month><Day>2</Day><Hour>12</Hour><Minute>47</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>10</Month><Day>17</Day><Hour>0</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>10</Month><Day>16</Day><Hour>23</Hour><Minute>37</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37845463</ArticleId><ArticleId IdType="doi">10.1007/978-3-031-42003-0_33</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Ballering AV, van Zon SKR, Hartman TCO, Rosmalen JGM (2022) Persistence of somatic symptoms after COVID-19 in The Netherlands: an observational cohort study. Lancet 400:452&#x2013;461</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(22)01214-4</ArticleId><ArticleId IdType="pubmed">35934007</ArticleId><ArticleId IdType="pmc">9352274</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis HE, McCorkell L, Vogel JM, Topol EJ (2023) Long COVID: major findings, mechanisms and recommendations. Nat Rev Microbiol 21:133&#x2013;146</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41579-022-00846-2</ArticleId><ArticleId IdType="pubmed">36639608</ArticleId><ArticleId IdType="pmc">9839201</ArticleId></ArticleIdList></Reference><Reference><Citation>WHO (2021) A clinical case definition of post COVID-19 condition by a Delphi consensus, 6 October 2021</Citation></Reference><Reference><Citation>Simonson TS, Baker TL, Banzett RB, Bishop T, Dempsey JA, Feldman JL et al (2021) Silent hypoxaemia in COVID-19 patients. J Physiol 599:1057&#x2013;1065</Citation><ArticleIdList><ArticleId IdType="doi">10.1113/JP280769</ArticleId><ArticleId IdType="pubmed">33347610</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang R, Dunn JF (2019) Multiple sclerosis disease progression: contributions from a hypoxia-inflammation cycle. Mult Scler 25:1715&#x2013;1718</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1352458518791683</ArticleId><ArticleId IdType="pubmed">30052113</ArticleId></ArticleIdList></Reference><Reference><Citation>De Blasi RA, Fantini S, Franceschini MA, Ferrari M, Gratton E (1995) Cerebral and muscle oxygen saturation measurement by frequency-domain near-infra-red spectrometer. Med Biol Eng Comput 33:228&#x2013;230</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/BF02523048</ArticleId><ArticleId IdType="pubmed">7643667</ArticleId></ArticleIdList></Reference><Reference><Citation>Fantini S, Hueber D, Franceschini MA, Gratton E, Rosenfeld W, Stubblefield PG et al (1999) Non-invasive optical monitoring of the newborn piglet brain using continuous-wave and frequency-domain spectroscopy. Phys Med Biol 44:1543&#x2013;1563</Citation><ArticleIdList><ArticleId IdType="doi">10.1088/0031-9155/44/6/308</ArticleId><ArticleId IdType="pubmed">10498522</ArticleId></ArticleIdList></Reference><Reference><Citation>Gatto R, Hoffman W, Mueller M, Flores A, Valyi-Nagy T, Charbel FT (2006) Frequency domain near-infrared spectroscopy technique in the assessment of brain oxygenation: a validation study in live subjects and cadavers. J Neurosci Methods 157:274&#x2013;277</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jneumeth.2006.04.013</ArticleId><ArticleId IdType="pubmed">16730069</ArticleId></ArticleIdList></Reference><Reference><Citation>Hallacoglu B, Sassaroli A, Wysocki M, Guerrero-Berroa E, Schnaider Beeri M, Haroutunian V et al (2012) Absolute measurement of cerebral optical coefficients, hemoglobin concentration and oxygen saturation in old and young adults with near-infrared spectroscopy. J Biomed Opt 17:081406&#x2013;081401</Citation><ArticleIdList><ArticleId IdType="doi">10.1117/1.JBO.17.8.081406</ArticleId><ArticleId IdType="pubmed">23224167</ArticleId><ArticleId IdType="pmc">3412596</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang R, Dunn JF (2015) Reduced cortical microvascular oxygenation in multiple sclerosis: a blinded, case-controlled study using a novel quantitative near-infrared spectroscopy method. Sci Rep 5:16477</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep16477</ArticleId><ArticleId IdType="pubmed">26563581</ArticleId><ArticleId IdType="pmc">4643232</ArticleId></ArticleIdList></Reference><Reference><Citation>Romero Starke K, Reissig D, Petereit-Haack G, Schmauder S, Nienhaus A, Seidler A (2021) The isolated effect of age on the risk of COVID-19 severe outcomes: a systematic review with meta-analysis. BMJ Glob Health 6:e006434</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjgh-2021-006434</ArticleId><ArticleId IdType="pubmed">34916273</ArticleId></ArticleIdList></Reference><Reference><Citation>Scholkmann F, Zohdi H, Wolf M, Wolf U (2022) Frontal cerebral oxygenation in humans at rest: a mirror symmetry in the correlation with cardiorespiratory activity. In: Oxygen transport to tissue XLIII, Cham, pp 45&#x2013;51</Citation></Reference><Reference><Citation>Lee M-H, Perl DP, Nair G, Li W, Maric D, Murray H et al (2020) Microvascular injury in the brains of patients with Covid-19. N Engl J Med 384:481&#x2013;483</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMc2033369</ArticleId><ArticleId IdType="pubmed">33378608</ArticleId></ArticleIdList></Reference><Reference><Citation>&#xd8;stergaard L (2021) SARS CoV-2 related microvascular damage and symptoms during and after COVID-19: consequences of capillary transit-time changes, tissue hypoxia and inflammation. Physiol Rep 9:e14726</Citation><ArticleIdList><ArticleId IdType="doi">10.14814/phy2.14726</ArticleId><ArticleId IdType="pubmed">33523608</ArticleId><ArticleId IdType="pmc">7849453</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>